These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 11105691
1. Delivery of therapeutic molecules into the CNS. Emborg ME, Kordower JH. Prog Brain Res; 2000; 128():323-32. PubMed ID: 11105691 [No Abstract] [Full Text] [Related]
2. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases. Barchet TM, Amiji MM. Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842 [Abstract] [Full Text] [Related]
3. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Begley DJ. Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907 [Abstract] [Full Text] [Related]
4. Intranasal delivery of biologics to the central nervous system. Lochhead JJ, Thorne RG. Adv Drug Deliv Rev; 2012 May 15; 64(7):614-28. PubMed ID: 22119441 [Abstract] [Full Text] [Related]
5. Nanotechnological applications for the treatment of neurodegenerative disorders. Modi G, Pillay V, Choonara YE, Ndesendo VM, du Toit LC, Naidoo D. Prog Neurobiol; 2009 Aug 15; 88(4):272-85. PubMed ID: 19486920 [Abstract] [Full Text] [Related]
12. Nanobiotechnology-based drug delivery to the central nervous system. Jain KK. Neurodegener Dis; 2007 May 15; 4(4):287-91. PubMed ID: 17627131 [Abstract] [Full Text] [Related]
13. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Gabathuler R. Neurobiol Dis; 2010 Jan 15; 37(1):48-57. PubMed ID: 19664710 [Abstract] [Full Text] [Related]
14. Targeted drug delivery to the brain; (blood-brain barrier, efflux, endothelium, biological transport). Terasaki T, Pardridge WM. J Drug Target; 2000 Jan 15; 8(6):353-5. PubMed ID: 11328661 [No Abstract] [Full Text] [Related]
15. Neurotrophins, neuroprotection and the blood-brain barrier. Pardridge WM. Curr Opin Investig Drugs; 2002 Dec 15; 3(12):1753-7. PubMed ID: 12528312 [Abstract] [Full Text] [Related]
16. Applications of nanotechnology in drug delivery to the central nervous system. Saeedi M, Eslamifar M, Khezri K, Dizaj SM. Biomed Pharmacother; 2019 Mar 15; 111():666-675. PubMed ID: 30611991 [Abstract] [Full Text] [Related]
17. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting. Correale J, Villa A. Autoimmunity; 2007 Mar 15; 40(2):148-60. PubMed ID: 17453713 [Abstract] [Full Text] [Related]
18. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Biochem Biophys Res Commun; 2006 Feb 24; 340(4):1085-90. PubMed ID: 16403441 [Abstract] [Full Text] [Related]
19. Drug delivery to the central nervous system: a review. Misra A, Ganesh S, Shahiwala A, Shah SP. J Pharm Pharm Sci; 2003 Feb 24; 6(2):252-73. PubMed ID: 12935438 [Abstract] [Full Text] [Related]
20. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." The blood-brain barrier: a physical and conceptual challenge. Hachinski V, Lee TY. Alzheimers Dement; 2009 Sep 24; 5(5):435-6. PubMed ID: 19751924 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]